engineered biosynthesis of tetracycline analogs.
Tetracyclines are aromatic polyketides biosynthesized by soil-borne streptomyces bacteria (1, 2) . It is well known that the carbon skeleton of an aromatic polyketide is assembled through stepwise decarboxylative condensation of malonate equivalents catalyzed by the minimal PKS, which consists of a ketosynthase/chain length factor heterodimer (KS-CLF or KS α -KS β ), an acylcarrier protein (ACP), and a malonyl-CoA:ACP acyltransferase (MAT) (3) . Dedicated tailoring enzymes transform the highly reactive poly-β-ketone backbone into fused, richly substituted compounds (4) . The biosynthesis of tetracyclines has been studied using blocked mutants of the chlorotetracycline producer Streptomyces aureofaciens (5) (6) (7) (8) (9) (10) (11) . However, the underlying enzymology of several key tailoring steps that give rise to its structural features remain unresolved, including cyclization of the tetracyclic scaffold and C-methylation of C-6 to afford the key intermediate 6-methylpretetramid ( Figure 1 ). The oxytetracycline (oxy) biosynthetic gene cluster from Streptomyces rimosus has been completely sequenced, hence allowing a thorough investigation of the biochemical basis of these features (12) (13) (14) (15) (16) .
During tetracycline biosynthesis, the C-9 reduced decaketide backbone first undergoes C-7/C-12 intramolecular aldol condensation to fix the regioselectivity of the D ring, followed by three sequential cyclization reactions to form a fully aromatized, tetracyclic intermediate pretetramid ( Figure 1 ). Biosynthesis of aureolic acids such as mithramycin presumably follows identical cyclization patterns, as inferred from the structure of premithramycinone, an early intermediate during mithramycin biosynthesis (17) . The biochemical basis of the C-1/C-18 cyclization reaction which affords the last rings in both tetracycline and mithramycin is not well understood. Combinatorial biosynthesis using mithramycin and tetracenomycin biosynthetic genes indicated that MtmX may function as a fourth ring cyclase (18) , although no direct 2 biochemical evidence is available. The oxy gene cluster encodes an MtmX homologue, OxyI, which may be involved in A ring cyclization. Compounds in the anthracycline family, such as daunorubicin, undergo identical cyclization reactions to fix the first three rings (Figure 1 ) (19) . Formation of the fourth, non-aromatic ring to yield alkaviketone during daunorubicin biosynthesis is catalyzed by the aklanonic acid methyl ester cyclase DnrD via distinct C-2/C-19 connectivity (20, 21) . The tetracenomycin family of compounds is constructed from fully aromatized intermediate tetracenomycin F1, but the regioselectivities are significantly different, starting with the first cyclization which occurs between C-9/C-14. The fourth ring cyclization takes place between C-2/C-19 and is catalyzed by a dedicated cyclase TcmI (22, 23) .
Another important structural feature of tetracyclines is a methyl group installed on C-6 of second ring. The methylation modification occurs relatively early during tetracycline biosynthesis as evidenced by isolation of the intermediate 6-methylpretetramid ( Figure 1 ) (8) .
The Cmethylation reaction is likely catalyzed by one of two methyltransferases in the oxy gene cluster (OxyF and OxyT), both containing putative Sadenosylmethionine (SAM) binding domains. Cmethyltransferases are found infrequently among bacterial type II PKSs, including MtmMII in the mithramycin gene cluster (24) , RemG and RemH from the resistomycin gene cluster (25) and the recently identified BenF and NapB2 from the benastatin (26) and napyradiomycin (27) gene clusters, respectively. All these Cmethyltransferases modify the respective aromatic aglycons with unique regiospecificity. Therefore, identification and reconstitution of the dedicated 6-methyltransferase in the oxytetracycline biosynthetic pathway will add to the molecular toolbox of tailoring enzymes.
Gene disruption through homologous recombination, followed by structure elucidation of the metabolites produced by the mutants has been widely used to access enzyme functions in polyketide biosynthetic pathways. However, gene inactivation has been demonstrated to be of limited use in studying oxytetracycline biosynthesis in S. rimosus. Genomic deletions of oxyK (28) and oxyS (29) in the oxy gene cluster led to the recovery of truncated polyketides only (30) and the resulting phenotypes cannot be directly associated with the functions of the deleted genes. The exact causes for biosynthesis of these truncated compounds in S. rimosus mutants are not understood.
Purification of target enzymes followed by in vitro biochemical characterizations are complicated by the inaccessibility of the substrates for the cyclization and methylation reactions of interest here. As a result of these technical difficulties, investigation of these early tailoring reactions can be performed through the systematic and incremental reconstitution of the pathway in a heterologous host.
Using a heterologous Streptomyces host and shuttle vectors containing different combinations of oxy genes, we recently reported the biosynthesis of novel amidated polyketides by coexpressing the oxy minimal PKS and OxyD (16, 31) . These studies verified that the amidotransferase homologue OxyD is a key enzyme in the biosynthesis of the amidated tetracycline backbone.
The main goal of this work is to elucidate the enzymes involved in formation of the tetracyclic scaffold and C-methylation of the aromatic aglycon. We compiled the minimal set of enzymes required to reconstitute 6-methylpretetramid biosynthesis in the heterologous host.
These results will enable additional investigation of oxytetracycline downstream tailoring steps and lead to the rational and combinatorial biosynthesis of tetracycline analogs.
EXPERIMENTAL PROCEDURES

Bacterial Strains and General Techniques for DNA Manipulation.
Streptomyces coelicolor strain CH999 (32) was used as a host for transformation of shuttle vectors. Protoplast preparation and PEG-assisted transformation were performed as described by Hopwood et al (33) . Escherichia coli XL-1 Blue (Stratagene) was used for the manipulation of plasmid DNA. PCR was performed using Platinum Pfx DNA polymerase (Invitrogen). PCR products were first cloned into a pCR-Blunt vector (Invitrogen) followed by DNA sequencing. Unmethylated DNA was obtained using the methylase-deficient strain GM2163 (New England Biolabs).
T4 DNA ligase (Invitrogen) was used for ligation of restriction fragments. The cosmid clone pYT264, which harbors the entire oxy gene cluster (16) , was used as the template for the amplification of individual oxy genes.
Construction of Plasmids. Primers used to amplify the individual genes are listed in Table S4 in supplemental information. Multicistronic cassettes were constructed using the compatible XbaI/SpeI/NheI cohesive ends for most of the genes. Different combinations of genes were introduced into pWJ35 (16) or pRM5 (32) to yield the constructs shown in Table 1 Table S1 for NMR spectral data.
Isolation of WJ83Q1-3 from S. coelicolor CH999/pWJ83. From the same extract as above, the methanol soluble fraction was dried in vacuo and redissolved in 5 mL of EA. The residue was first chromatographed on a normal-phase silica gel (150 g) column and eluted with ethyl acetate in 1% acetic acid to give two impure fractions containing 3 and 4 (R f value 0.72 and 0.3 respectively). Further purification of 3 and 4 were achieved on a preparative reverse-phase HPLC column (XTerra Prep MS C18 OBD Column, 5µm, 19X50mm) and a 30% -80% CH 3 CN in water (0.1% TFA) gradient was used over 45 min with a flow rate of 3 mL/min. 4 and 3 crystallized as pure yellow/orange needles after elution from the column, with retention times of 8.6 and 17.8 min, and approximate yields of 5 and 2 mg/liter, respectively. The MeOH soluble fraction of the crude extract was also directly applied to the preparative reverse-phase HPLC column to give pure 2 (approximate yield of 8 mg/liter with retention time of 11.2 min at the same gradient as above). WJ83Q2 (2) Table S2 and S3 (supporting information) for NMR spectral data.
Isolation of WJ119 (6) from S. coelicolor CH999/pWJ119. Seventy R5 plates (2 liter) streaked with the CH999/pWJ119 were incubated at 30°C for 8 days. The plates were extracted with 2 liter of EA/MeOH/acetic acid (94%/5%/1%). The solvent was removed in vacuo, and the residue was first chromatographed on a normalphase silica gel (100 g) column and eluted with EA in 1% acetic acid to give impure yellow fractions containing 6 (R f value 0.38). Further purification of 6 was achieved on a preparative reverse-phase HPLC column (SunFire Prep C18 OBD Column, 5µm, 19X50mm). A 5% -95% CH 3 CN in water (10 mM TEA) gradient was used over 30 min with a flow rate of 3 ml/min to give yellow fractions containing 6 with a retention time of 12.4 min. The pH of the eluent was adjusted to ~2 with 6 N HCl, extracted with EA and dried in vacuo to give pure solid 6 (approximate yield of 58 mg/liter). WJ119 (6) Table S1 for NMR spectral data.
Enzyme Purification and in vitro Assays. Gris ARO/CYC, OxyN, OxyI and holo-OxyC were expressed and purified from E. coli strains BL21(DE3)/pWJ184, BL21(DE3)/pWJ181, BL21(DE3)/pWJ189 and BAP1/pWJ66, respectively (see supporting information for details). ActIII ketoreductase (KR) and MAT were expressed in E. coli and purified as described previously (34,35). OxyAB was purified from CH999/pWJ131. The in vitro assays converting malonyl coenzyme A (malonyl-CoA) into aromatic polyketides were performed in reaction buffer [100 mM NaH 2 PO 4 (pH 7.4), 2 mM MgCl 2 and 10% glycerol].
Each reaction mixture contained 2 mM malonyl-CoA, 300 nM MAT, 20 µM Holo-OxyC and 10 µM OxyAB in a final volume of 100 µL. All other enzymes were added to final concentrations between 20 and 100 µM. NADPH (2 mM final concentration) was added as needed. Reactions were initiated by adding the substrate malonyl-CoA and incubated at 30 °C for 2 hours. The reaction mixture was extracted with EA/acetic acid (99%/1%), and the organic phase was dried in a speedvac and redissolved in 20 µL of DMSO and analyzed with HPLC.
RESULTS
We constructed a series of plasmids to identify the minimal set of enzymes required to afford the key intermediate 6-methylpretetramid. The genes of interest were systematically introduced into the E. coli/S. coelicolor shuttle vector as shown in Table 1 . The plasmids were transformed into the engineered S. coelicolor host CH999 (32) and the production of polyketides by the host/vector pairs were assayed by LC/MS.
Functional study of OxyN. Our previous study had identified that OxyABCDJ were essential and sufficient to produce the amidated decaketide tetracycline backbone with good yield in CH999 (16) . Furthermore, OxyK was identified by Petkovic et al (28) and confirmed in our lab to be the bifunctional cyclase/dehydratase that is responsible for formation of the D ring through C-7/C-12 cyclization (Figure 2 ). OxyN showed strong sequence similarity to DpsY (36) and MtmY (37) , which catalyze cyclization of the second ring during daunorubicin and mithramycin biosynthesis, respectively. We tested the function of OxyN through coexpression with the oxy minimal PKS, OxyJ, OxyK, and OxyD in plasmid pWJ83.
CH999/pWJ83 grown on R5 agar developed rust-colored, non-diffusible pigmentation in the mycelia.
Several new biosynthetic products were detected from the CH999/pWJ83 extract and were partitioned with methanol and purified separately. The methanol insoluble fractions contained the most abundant compound produced by this strain. WJ83T1 (1) was isolated at ~55 mg/liter after reversed-phase HPLC purification. The UV spectrum of the compound in dilute acid showed absorption maxima at 278 nm and a broad peak at 500 nm, which is indicative of an extended chromophore. The compound exhibited a bathochromic shift and developed a deep purple color with the addition of NaOH (λ max = 566 nm). HR-ESIMS indicated the molecular formula of C 19 H 11 NO 7 for 1, consistent with the molecular composition of an amidated decaketide (Figure 2 ). The 13 C NMR spectrum (Table S1) Accumulation of the linear, tetracyclic 1 as a major product in CH999/pWJ83 demonstrates that only two cyclases (OxyK and OxyN) were necessary to cyclize all four rings in tetracycline. Oxidation of ring C to a quinone was likely a spontaneous, nonenzymatic modification that is widely observed for aromatic polyketides (32, (38) (39) (40) . LC-MS analysis indicated the likely presence of trace amount of the acetyl-primed version of 1 (m/z 364.1) in the extract of CH999/pWJ83.
Numerous anthraquinone compounds were recovered from the methanol-soluble fraction of the CH999/pWJ83 extract. Reverse-phase HPLC purification yielded an orange-pigmented metabolite WJ83Q2 (2a) at ~8 mg/L (Figure 2 ). WJ83Q2 has strong UV absorptions at 228, 257 and 430 nm and has a molecular formula of C 19 H 14 NO 8 .
The 1 H spectrum showed four aromatic proton signals, two methylene singlets and two broad 1 H signals at δ H = 7.12 and 7.52 ppm identified as amide protons. 2a is the amidated version of the well-known metabolite aklanonic acid, which is an intermediate in the anthracycline biosynthetic pathways (Figure 1 ) (41) . NMR analysis in DMSO-d 6 also showed both the C-17/C-18 keto (2a) and enol (2b) isoforms were present with an equilibrium ratio of 2 to 3. Furthermore, after two days at room temperature in DMSO-d 6 , 2a and 2b were completely decarboxylated to 2c and 2d as indicated by NMR and LC-MS analysis (Table S2 ). The acetyl-primed version of 2, desmethylaklanonic acid (5), was also purified from the methanol-soluble fraction (~4.5 mg/L).
Two minor orange-pigmented metabolites, WJ83Q3 (3) and WJ83Q1 (4), were isolated from CH999/pWJ83 (Figure 3 ). Compound 3 (2 mg/L) had a molecular composition of C 19 H 12 O 5 , which indicated that it may be an acetyl-primed decaketide that has undergone loss of one CO 2 .
NMR spectra (Table S3) Compound 4 (~5 mg/L) has the molecular formula C 16 H 11 NO 5 and the structure of the novel amidated anthraquinone derived from an amidated nonaketide backbone (9 C=O) was determined as shown in Figure 3 (See Table S3 for NMR data). The presence of an amidated, truncated shunt product is not surprising and further confirmed that OxyAB may not be able to exert complete chain length control. Hunter and coworkers have reported the isolation of truncated polyketides from S. rimosus mutant strains containing genomic deletions in oxyK and oxyS (28, 29) . However, in contrast to those studies, the full length products 1-3 were the dominant metabolites produced by CH999/pWJ83.
Other truncated polyketides produced by this strain include the acetyl-primed octaketide 3,8-dihydroxy-methylanthraquinone carboxylic acid (DMAC) (32), which was recovered at yield < 0.5 mg/L. We then constructed pWJ196 in which oxyN was replaced with dpsY from the daunorubicin biosynthetic pathway. CH999/pWJ196 produced the identical distribution of polyketides with 1 being the dominant product. This is unexpected since DpsY was previously demonstrated to only catalyze cyclization of the second, and possibly the third rings during daunorubicin synthesis (45) .
To compare the cyclization events between acetyl-derived and malonamoyl-derived polyketides, we constructed plasmid pWJ83c in which oxyD was removed from pWJ83. CH999/pWJ83c produced 5 as the major product, while no trace of tetracyclic compounds can be detected by LC-MS analysis. This provided direct evidence that the terminal amide unit, which is installed by OxyD, is important for the final by guest on October 5, 2017 http://www.jbc.org/ Downloaded from cyclization step leading to the formation of 1. To further demonstrate that acetyl-derived decaketides cannot form tetracyclic aglycons with only two cyclases, we performed in vitro assay with purified oxy PKS components. OxyAB was purified from CH999/pWJ131 with a yield of ~2 mg/L (supporting information). Holo-OxyC and OxyN were expressed and purified from E. coli expression strains. OxyJ and OxyK formed inclusion bodies when expressed in E. coli. As a substitute, the functionally equivalent ketoreductase ActIII (16,34) and cyclase Gris ARO were expressed, purified and assayed (46) . Malonyl-CoA and MAT were added to different combinations of PKS enzymes and the polyketide products were extracted and analyzed by HPLC ( Figure S1 , Supporting Information). The minimal PKS (OxyABC) produced SEK15, while the sequential addition of ActIII and Gris ARO led to the synthesis of RM20b and SEK43 as major products, respectively. Addition of OxyN led to formation of 5, while no trace of tetracyclic compounds can be detected by LC-MS analysis, consistent with in vivo results.
Functional study of OxyI. OxyI was originally assigned (16) as the fourth ring cyclase during oxytetracycline biosynthesis based on its high sequence homology to MtmX in the mithramycin biosynthetic pathway. To examine if coexpression of OxyI can lead to complete cyclization of the decaketides characterized in CH999/pWJ83, we constructed pWJ90, in which oxyI was inserted immediately downstream of oxyN. The LC-MS profile of the extract of CH999/pWJ90 was identical to that of CH999/pWJ83 with all the aforementioned products present at comparable yields and the ratio of 1 to 2 remained at ~ 7:1. These results indicate that OxyI has no apparent cyclase functions in the oxy biosynthetic pathway and cyclization of the fourth ring in tetracycline can take place in the presence of only two cyclases.
Functional study of OxyF. OxyF and OxyT are the two putative SAM dependent methyltransferases present in the oxy gene cluster (16) . To identify the enzyme responsible for C-6 methylation that affords 6-methylpretetramid, we constructed shuttle vectors in which the gene encoding OxyT or OxyF was added to pWJ83 to yield pWJ120 and pWJ119, respectively.
Extraction of CH999/pWJ120 yielded the same metabolite profile as that of CH999/pWJ83, indicating OxyT has no apparent function in this strain. In contrast, the extract of CH999/pWJ119 contained <1% of 1 observed in CH999/pWJ83 as a result of OxyF coexpression, with the accompanying appearance of a new major metabolite WJ119 (6), which had a distinct UV spectrum with λ max at 435 nm.
The new compound was highly soluble in methanol and was isolated (58 mg/L) after normal-phase silica gel chromatography and reversed-phase HPLC purification. HR-ESIMS indicated the molecular formula of C 20 H 15 NO 7 for 6, which is consistent with the introduction of an extra methyl group to 1. HSQC experiment (Table S1) carbon atom connected to an -OH group, and is evidence for a non-aromatic ring C. We concluded that 6 is the oxidized form of 6-methylpretetramid with a hydroxyl group introduced at C-6 (Figure 2 ), likely as a result of air oxidation during purification. Biosynthesis of 6 by CH999/pWJ119 proved the involvement of OxyF in the C-6 methylation reaction. The anthraquinones 2-5 were also present in the extract of CH999/pWJ119 at the same levels, while LC-MS indicated the possible presence of the acetylprimed version of WJ119 in very trace amounts.
To probe whether OxyF can be combinatorially combined with other aromatic PKSs towards the synthesis of novel, methylated polyketides, we coexpressed OxyF in CH999 strains producing DMAC (act PKS, CH999/pWJ123) (32), dodecaketides (pdm PKS, CH999/pWJ180) (47) or tetracenomycin F2 (tcm PKS, pWJ190) (48) . No new metabolites were detected in those strains, indicating OxyF has high specificity towards its natural substrates in the oxy biosynthetic pathway.
DISCUSSION
In this work we successfully constructed heterologous strains that synthesized key intermediates of the oxytetracycline biosynthetic pathway. This work is an important step in understanding and engineering tetracycline biosynthesis because 1) the presence of the carbamoyl moiety in 1 and 6 further validates the essential role of OxyD for tetracycline biosynthesis; 2) complete cyclization of the amidated decaketide backbone confirms the role of the cyclases in the oxy cluster; and 3) regioselective C-6 methylation specifies the function of the C-methyltransferase, OxyF; and 4) the strain CH999/pWJ119 is a suitable platform for systematic and combinatorial analysis of additional oxy downstream tailoring enzymes.
The various metabolites recovered from CH999/pWJ83 and CH999/pWJ119 provide insights into the possible mechanisms of these early tailoring steps. Formation of ring C clearly proved that OxyN catalyzes the C-5/C-14 aldol reaction. No additional enzyme was needed to completely cyclize ring B, consistent with the biosynthetic mechanism of most aromatic polyketides, such as aklanonic acid and DMAC (36, 45) . Surprisingly, cyclization of the ring A of amidated polyketides to yield pretetramid occurred without coexpression of additional cyclases. This is in contrast to the assembly of alkylacyl-primed, tetracyclic polyketides (Figure 1) , in which cyclization of the fourth ring is catalyzed by dedicated enzymes (20, 22) . This was in fact observed in the extracts of CH999/pWJ83 and CH999/pWJ83c, where acetyl-primed decaketides did not undergo fourth ring cyclization (see 3 and 5).
Amide-dependent formation of ring A is unlikely to be catalyzed by OxyN, since the replacement of OxyN with DpsY let to the exact same product distribution. It is difficult to rationalize that DpsY from a propionyl-primed pathway has evolved the required substrate specificity towards malonamyl-primed polyketides. We therefore propose cyclization of ring A occurs spontaneously only in the presence of the terminal amide. As shown in Figure 2 , intramolecular C-1/C-18 aldol condensation of the anthracene carbonyl-S-OxyC, followed by concomitant release of the OxyC-SH affords the naphthacene compound pretetramid (pathway A), while spontaneous hydrolysis of the tricyclic intermediate yields the anthracene carboxylic acid (pathway B). The ratio of tetracyclic to tricyclic compounds is thus dictated by the relative rates of these two pathways in vivo. We hypothesize that installment of the amide group at C-19 may stabilize the anthracene carbonyl-S-OxyC complex against spontaneous hydrolysis, possibly by formation of hydrogen bonds with amino acid residues on helix 2 of OxyC.
The polyketide:OxyC interaction increases the relative rate of pathway A and leads to the synthesis of the key intermediate pretetramid. As a result, a high ratio of 1 to 2 (~7:1) was observed in the extract of CH999/pWJ83. In the absence of the stabilizing polyketide:OxyC interactions, as in the alkylacylprimed polyketides, hydrolysis of the thioester bond occurs readily and only trace amounts of the tetracyclic compounds can be synthesized. The same polyketide:OxyC interaction facilitated by the amide start unit may also account for the unusual cyclization patterns observed for the polyketides WJ35 (16) and WJ85 (31) .
Our work also unequivocally proved that OxyF is the C-6 methyltransferase in the oxy biosynthetic pathway. Near complete methylation of pretetramid to 6-methylpretetramid was observed upon coexpression of OxyF, while the yields of tricyclic compounds 2-5 remain unchanged. We did not detect any derivatives of 2 and 5 that are methylated at the C-6 positions. From these in vivo results we reason the OxyFcatalyzed methylation reaction occurs on the tetracyclic scaffold, and anthracene compounds are not substrates of OxyF (Figure 2 ). The proposed mechanism for OxyF is shown in Figure  4 . Base-catalyzed deprotonation of free C-13 phenolic -OH leads to the generation of a C-6 carbanion. The nucleophilic C-6 then attacks the CH 3 + equivalent residing on SAM to form the observed carbon-carbon bond. The methylation reaction must proceed prior to the spontaneous oxidation of the C ring, as installment of a quinone at C-6 deactivates formation of the nucleophilic C-6.
Another interesting finding is that there is significant increase in the relative yields of malonamyl-derived to acetyl-derived metabolites when more tailoring enzymes are coexpressed with the oxy minimal PKS ( Figure 5 ). With only the extended oxy minimal PKS (OxyABCD, in CH999/pWJ85), equal amounts of amidated (WJ85) to non-amidated (SEK15) polyketides were isolated (31) . Insertion of the C-9 reductase OxyJ increases the ratio to ~4 with WJ35 becoming the major compound over RM20/b/c (16) . Addition of the first ring cyclase OxyK further increases the amount of amidated polyketides (data not shown). In this work, when OxyN and OxyF were coexpressed, amidated polyketides were produced ~10 times the level of non-amidated polyketides.
These systematic increases in the amount of malonamyl-derived compounds strongly suggest the downstream enzymes enforce significant influence on the incorporation of the amide functionality during polyketide synthesis. Although we confirmed the essential role of OxyD in introducing the amide group during tetracycline synthesis, the exact timing and substrates of the reaction have not been determined.
The striking observation in Figure 5 can be explained by several possible models: 1) increased activity of OxyD in the presence of tailoring enzymes, which results in elevated levels of the malonamyl primer unit; 2) increased selectivity of the minimal PKS towards the malonamyl starter unit through unknown proteinprotein interactions with the tailoring enzymes. This was previously observed for the enterocin minimal PKS where coexpression of the endogenous ketoreductase is essential for the synthesis of benzoyl-primed polyketides (49); or 3) the incorporation of the malonamyl primer unit favors turnover of downstream tailoring steps. Our investigation of cyclization and methylation reactions in this work showed that the presence of amide unit is necessary for the complete cyclization of the tetracycline aglycon, which then serves as substrates for next tailoring enzyme OxyF. The final mechanism that can satisfactorily explain the trend in Figure 5 may be a combination of the models above and we are currently investigating this intriguing phenomenon. The observed ratios for amidated polyketides to nonamidated polyketide produced by the various heterologous host/vector pairs. As the number of tailoring enzymes is increased, the amount of amidated polyketides increases correspondingly. S. coelicolor CH999 is used as host in these studies. 
